Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Litzow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1986 - 1989- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1980 - 1984
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
Certifications & Licensure
MN State Medical License 1981 - 2027
MT State Medical License 2013 - 2025
AZ State Medical License 2013 - 2024
FL State Medical License 2013 - 2024
IA State Medical License 2013 - 2024
MI State Medical License 2013 - 2024
ND State Medical License 2014 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2017
Clinical Trials
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 1993 May 07
- Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia Start of enrollment: 2000 Oct 04
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2000 Jun 01
Publications & Presentations
PubMed
- Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.Daniela R Anderson, Radhika Gangaraju, Wafik George Sedhom, Eva N Hamulyák, Tzu-Fei Wang
Blood Advances. 2026-02-10 - Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in-mutated myelodysplastic syndromes.Mahmood Aldapt, Yu-Hung Wang, Kashish J Shah, Mobachir El Kettani, James Foran
Haematologica. 2026-01-08 - Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.Talha Badar, Ludovica Marando, Eric Latorre-Crespo, Terra L Lasho, Francyess Denis Oliva
Blood Advances. 2026-01-07
Journal Articles
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Ri...Joshua F Zeidner, Mark R Litzow, Jeffrey E Lancet, Prithviraj Bose, Raoul Tibes, Ivana Gojo, Richard F Little, Judith E Karp, Leukemia Research
- Does Matching for SNPs in the MHC Gamma Block in 10/10 HLA-Matched Unrelated Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant Improve Outcomes?Eapen K Jacob, Shahrukh K Hashmi, Justin D Kreuter, William J Hogan, Dennis A Gastineau, Ann M Moyer, Mark Litzow, ScienceDirect
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabMark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Mark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504...Mark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia60th American Society of Hematology Annual Meeting - 12/3/2018
- A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia60th American Society of Hematology Annual Meeting - 12/1/2018
Authored Content
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Risk Acute Myeloid Leukemia (AML)August 2018
Press Mentions
Top Cancer Research Stories of 2024December 30th, 2024- Chemotherapy and Tyrosine Kinase Inhibitor Therapy May Improve Overall Survival in ALLNovember 26th, 2024
- myeloMATCH Program Opens Enrollment for Acute Myeloid Leukemia and MDSOctober 22nd, 2024
Grant Support
- Dendritic Cell Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute2001–2003
- Trial Of Recombinant Interleukin-3 And GM-CSFNational Center For Research Resources1994–1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
